Red Cedar Investment Management LLC Acquires 306 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Red Cedar Investment Management LLC grew its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 4.9% during the fourth quarter, HoldingsChannel.com reports. The firm owned 6,573 shares of the healthcare conglomerate’s stock after buying an additional 306 shares during the period. Red Cedar Investment Management LLC’s holdings in UnitedHealth Group were worth $3,460,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the stock. Bray Capital Advisors increased its stake in UnitedHealth Group by 0.5% in the third quarter. Bray Capital Advisors now owns 9,616 shares of the healthcare conglomerate’s stock valued at $4,848,000 after purchasing an additional 50 shares in the last quarter. Litman Gregory Wealth Management LLC bought a new position in UnitedHealth Group during the third quarter worth about $11,680,000. Live Oak Private Wealth LLC raised its position in shares of UnitedHealth Group by 0.8% during the third quarter. Live Oak Private Wealth LLC now owns 23,212 shares of the healthcare conglomerate’s stock worth $11,703,000 after purchasing an additional 179 shares during the period. Hexagon Capital Partners LLC grew its position in shares of UnitedHealth Group by 3.6% in the 3rd quarter. Hexagon Capital Partners LLC now owns 1,083 shares of the healthcare conglomerate’s stock valued at $546,000 after purchasing an additional 38 shares during the period. Finally, Cambridge Investment Research Advisors Inc. raised its holdings in UnitedHealth Group by 5.4% during the 3rd quarter. Cambridge Investment Research Advisors Inc. now owns 131,333 shares of the healthcare conglomerate’s stock worth $66,217,000 after buying an additional 6,777 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

UNH stock traded down $0.52 during midday trading on Friday, reaching $492.45. 2,487,811 shares of the company were exchanged, compared to its average volume of 5,130,659. The business has a 50-day moving average price of $482.32 and a two-hundred day moving average price of $512.76. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79. The firm has a market capitalization of $453.09 billion, a price-to-earnings ratio of 30.10, a price-to-earnings-growth ratio of 1.43 and a beta of 0.55. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $554.70.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.63 by $0.28. The firm had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The business’s revenue for the quarter was up 8.6% compared to the same quarter last year. During the same period last year, the business posted $6.26 earnings per share. Equities research analysts forecast that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were given a $1.88 dividend. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.53%. UnitedHealth Group’s payout ratio is presently 45.97%.

Insider Buying and Selling

In other news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now directly owns 32,289 shares in the company, valued at approximately $16,977,233.31. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on UNH. Truist Financial reissued a “buy” rating and set a $600.00 price objective on shares of UnitedHealth Group in a research report on Wednesday, April 17th. Barclays upped their price objective on UnitedHealth Group from $534.00 to $560.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 17th. Wells Fargo & Company cut their target price on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating on the stock in a research note on Monday, April 8th. Royal Bank of Canada decreased their price target on shares of UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating for the company in a research note on Wednesday, April 17th. Finally, Oppenheimer restated an “outperform” rating and set a $610.00 target price on shares of UnitedHealth Group in a report on Wednesday, January 17th. Four equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $570.05.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.